R. Love

发表

Identification of Cys255 in HIF‐1α as a novel site for development of covalent inhibitors of HIF‐1α/ARNT PasB domain protein–protein interaction

Ping Chen, Simon Bergqvist, Kevin K-C Liu, 2012, Protein science : a publication of the Protein Society.

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

M. Hickey, J. Thomson, P. Dragovich, 2003, Journal of Virology.

Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site.

A. D. Clark, S. Hughes, E. Arnold, 2009, Structure.

Structural studies of alpha-bungarotoxin. 1. Sequence-specific 1H NMR resonance assignments.

I. Kuntz, M. Billeter, R. Stroud, 1988, Biochemistry.

How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate.

W. Butler, J. E. Villafranca, R. Jue, 1993, Biochemistry.

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus (cid:1)

M. Hickey, P. A. Wells, O. Brodsky, 2009 .

The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.

H. Parge, E. W. Moomaw, N. Habuka, 1998, Clinical and diagnostic virology.

Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.

D. Matthews, T. Hendrickson, S. Webber, 1998, Journal of medicinal chemistry.

Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.

D. Matthews, T. Hendrickson, S. Webber, 1996, Journal of medicinal chemistry.

Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.

D. Matthews, T. Hendrickson, S. Webber, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Design , Synthesis , and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3 C Protease

D. Matthews, T. Hendrickson, S. Webber, 2022 .

Evidence for conformational differences in aqueous and crystalline structures of α-bungarotoxin and cobratoxin

R. Stroud, G. Thomas, R. Love, 1986 .

The Crystal Structure of Hepatitis C Virus NS3 Proteinase Reveals a Trypsin-like Fold and a Structural Zinc Binding Site

H. Parge, E. W. Moomaw, N. Habuka, 1996, Cell.

Subunit organization and structure of an acetylcholine receptor.

R. Stroud, J. Finer-Moore, R. Love, 1983, Cold Spring Harbor symposia on quantitative biology.

Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors.

A. Patick, K. Maegley, R. Love, 2007, Antiviral research.

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

M. Hickey, P. A. Wells, O. Brodsky, 2009, Journal of Virology.

The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor.

R M Stroud, R. Stroud, R. Love, 1986, Protein engineering.

The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy.

P. Dragovich, H. Parge, R. Ferre, 2004, Structure.

Homodimerization of the PAS-B domains of hypoxia-inducible factors.

H. Dyson, N. Grodsky, Jiangli Yan, 2012, The journal of physical chemistry. B.

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

Robert A. Love, Xiu Yu, Hans E. Parge, 2003, Journal of Virology.

Interaction of a novel GDP exchange inhibitor with the Ras protein.

J. Brown, M. Snow, C. Kissinger, 1998, Biochemistry.

Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex.

L. Perkins, S. Liberles, J. Brown, 1997, Bioorganic & medicinal chemistry.

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

M. Hickey, P. A. Wells, O. Brodsky, 2009, Journal of Virology.

Identification of Cys255 in HIF‐1α as a novel site for development of covalent inhibitors of HIF‐1α/ARNT PasB domain protein–protein interaction

H. Dyson, Ping Chen, Jiangli Yan, 2012, Protein science : a publication of the Protein Society.